Probiotic marketing in 2025 has converged on a single headline number: CFU count. Colony-forming units, displayed in increasingly large fonts on increasingly aggressive packaging — 10 billion! 50 billion! 100 billion! The implication is that more is better, and that picking a probiotic is mostly an exercise in finding the highest number.
This is wrong in almost every way that matters. Strain identity, not CFU count, is what determines whether a probiotic is going to do anything for you.
What CFU actually measures
Colony-forming units is a measure of how many viable, capable-of-reproducing bacterial cells are present in a sample. It's a real and useful number — it tells you that the product hasn't died on the shelf, and it gives you a rough sense of dose.
What it doesn't tell you is whether those bacteria are the right bacteria for what you want them to do. A trillion CFU of the wrong species in the wrong place is a placebo with extra steps. A few billion CFU of the right species in the right place can produce measurable effects in well-controlled trials.
The hierarchy that actually matters
When you read a probiotic label, the order of importance is:
- Genus (Lactobacillus, Bifidobacterium, Saccharomyces, Bacillus, etc.) — the broad category.
- Species (L. crispatus, L. rhamnosus, L. acidophilus) — the specific organism.
- Strain (GR-1, RC-14, La-14, NCFM) — the specific lineage of that species, with specific characteristics. This is what matters most.
- CFU count — how many of them are in the bottle.
- Delivery format — capsule type, refrigeration requirement, gut-survival mechanism.
The CFU count, the thing the marketing screams about, is the fourth item in this hierarchy. And it's the one that tells you the least about whether the product will do anything.
Why strain matters so much
Within a single bacterial species, different strains can have radically different properties. Two strains of L. rhamnosus can differ in their ability to colonise different parts of the human body, in their production of beneficial compounds, in their interaction with the immune system, in their stability in capsule form, in their survival through stomach acid.
This isn't theoretical. In the women's-health literature specifically, there are dozens of L. rhamnosus strains. Only one — GR-1 — has the multi-decade clinical research base supporting its persistence in the vaginal flora and its synergy with the vaginal microbiome. A different strain of the "same" species might do nothing.
The same is true of nearly every well-studied probiotic. The clinical research is at strain level. The marketing is at species level. The gap is where most consumer probiotics sit.
How to read a probiotic label
Some practical guidance:
Good signs
- Specific strain identifiers — alphanumeric codes after the species name (GR-1, La-14, RC-14, etc.).
- Reference to specific clinical research — usually citation by author or trial name.
- CFU count guaranteed at end of shelf life, not "at time of manufacture" (which can drop by 50% before reaching you).
- Reasonable rather than absurd CFU counts — 1-10 billion of well-targeted strains often outperforms 100+ billion of generic strains.
- Delivery technology appropriate to the destination — gut probiotics need acid-resistant capsules; vaginal-targeted probiotics need different considerations.
Warning signs
- "Proprietary blend" on a probiotic label. This is the equivalent of a wine list that says "alcoholic beverages" — you have no idea what you're getting.
- Genus or species only, no strain. "Contains Lactobacillus acidophilus" without an identifier means the manufacturer either doesn't know or doesn't want you to know.
- Headline CFU counts in the trillions. Possible, but at that scale you're often paying a premium for marketing rather than meaningful efficacy.
- Vague claim language — "supports gut health," "promotes balance" — without any reference to what specifically the strains have been studied for.
Every strain in FloraGuard is named at the strain level on the label: L. crispatus CTV-05, L. rhamnosus GR-1, L. reuteri RC-14, L. acidophilus La-14. Each was selected because it has, individually, peer-reviewed published research supporting its role in the vaginal microbiome. The CFU count is reasonable rather than dramatic — 6 billion total, guaranteed at end of shelf life, distributed across the four strains in proportions matching the trial doses.
The honest summary
The probiotic industry has trained consumers to compare on CFU count because CFU count is easy to print large on a box. But CFU count tells you almost nothing about whether the strains in the box will do what you want them to do.
Read the strain identifiers. Look up the strain identifiers. Take the brands that name them seriously, and approach the brands that don't with appropriate scepticism. The information you need is on the label — once you know what to look for.